MedTrace Logo

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

NCT05736081 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-08-02

No results posted yet for this study

Summary

The goal of this clinical trial es to learn about the short term effects of intravitreal dexamethasone implant (IDI) in patients with refractory diabetic macular edema. The main question it aims to answer is:

How fast does the diminishing in central retinal thickness has statistical significance after IDI in patients with refractory diabetic macular edema? Patients will be evaluated by OCT before and after the implant.

Conditions

Interventions

DRUG

Intravitreal dexamethasone implant

Intravitreal implant of dexamethasone 0.7 mg with previous topic anesthesia and iodine drops

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • José Gerardo García Aguirre, MD · Asociación para Evitar la Ceguera en México I.A.P.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2019-06-30
Completion
2019-06-30
FDA Drug
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05736081 on ClinicalTrials.gov